LoreaTec BizSearch
English|日本語

一般社団法人未来医療推進機構

Tokyo, Japan

No invoice registration
Invoice registrationNot registered as a qualified invoice issuer
TypeCorporation
Registered name一般社団法人未来医療推進機構
Address東京都港区
Minato-ku, Tokyo, JAPAN
Corporate number6010405023300
Corporate number assigned on2024-06-13

Corporate registry record

Entity typeOther registered corporation
Reading (furigana)ミライイリョウスイシンキコウ
Reading (romaji)Miraiiryosuishinkiko
English name (unofficial)Miraiiryosuishinkiko General Incorporated Association
Postal code107-0062

Source: NTA Corporate Number Publication Site, refreshed daily.

Timeline — registry changes

2024-06-13Newly registered (corporate number assigned)

Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →

Government contract awards (GEPS)

No public national-government (GEPS) award records for this company in the open data (FY2013 to date).

Browse the awards database →

出典:調達ポータル(https://www.p-portal.go.jp/)

Payments from national budget programmes (行政事業レビュー)

Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2024–2024; total ¥526.1M).

2024
FY2023
再生・細胞医療・遺伝子治療の社会実装に向けた環境整備事業 ¥526.1M (経済産業省)
科学的・客観的データによって治療効果を確立し、再生・細胞医療・遺伝子治療の社会実装を推進する。

Contract details (excerpt): 未来医療国際拠点を中核とした、再生・細胞治療・遺伝子治療の基盤整備 ¥526.1M・補助金等交付 · bidders 9

Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →

Doing due diligence on this supplier?

Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.

Read the guide

How to cite this page

Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t6010405023300) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.

Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence